Le Lézard
Classified in: Science and technology
Subjects: PLW, MRR

Microfluidic Devices Patent Monitoring Service: Keep Watch on Your Competitors' IP Activities and Future Intentions


DUBLIN, Oct. 19, 2023 /PRNewswire/ -- The "Microfluidic Devices Patent Monitor" newsletter has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

Microfluidic is a well-established growing market with successful applications in several industrial areas

Microfluidics, a field that emerged in the early 1980s, encompasses a wide range of applications, including the development of technologies like inkjet printheads, DNA chips, lab-on-a-chip systems, and point-of-care devices. It is a multidisciplinary domain that intersects with engineering, physics, chemistry, biochemistry, nanotechnology, and biotechnology.

Within this expansive technical realm, there has been a prolific surge in patent activity. More than 20,000 patent families related to microfluidics have been published worldwide, and this number continues to grow with over 150 new patent families emerging each month. Many major corporations such as HP, BOSCH, ABBOTT, and ROCHE are highly engaged in intellectual property activities in this field, and startups are consistently filing new patent applications.

Furthermore, market forecasts predict robust growth in the microfluidics industry for the coming decades. There is a global demand for microfluidic technology, with North America accounting for over 40% of the market share, followed by Europe with over 30%, and the Asia Pacific region contributing around 20%.

Given the rapid expansion and dynamic nature of the microfluidics market, it is crucial to monitor patents to anticipate shifts, identify new entrants and business prospects, manage risks, and make strategic decisions.

The microfluidic devices patent monitoring service offers a comprehensive solution. It provides a monthly updated Excel file containing information on new patents, expired or abandoned patents, patent transfers (re-assignments and licensing agreements), and patent litigation or opposition. Patents are categorized by application segments such as point of care (PoC), cell sorting, drug delivery, IC cooling, inkjet technology, and more.

This Excel patent database facilitates multi-criteria searches, including priority dates, patent assignees, claims, legal status of patents, and technology segments. Quarterly reports offer insights into intellectual property trends over the preceding three months, focusing on key players and patented technologies.

Additionally, direct access to our analysts enables Q&A sessions and open discussions regarding specific patented technologies or company IP portfolios.

Benefits of the patent monitoring service

Key features of the service

For more information about this newsletter visit https://www.researchandmarkets.com/r/r2o1hq

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected] 

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets


These press releases may also interest you

at 16:05
Hologic, Inc. announced today the Company's financial results for the fiscal second quarter ended March 30, 2024. "At Hologic we continue to deliver, exceeding the high-end of our guidance for both the top and bottom-line, highlighting our durable...

at 16:05
Expedia Group, Inc. announced financial results today for the first quarter ended March 31, 2024. "Our first quarter results met our guidance with a revenue and earnings beat but with less robust gross bookings. We saw continued momentum in B2B,...

at 16:05
After market close on Thursday, May 30, 2024, NetApp will announce financial results for the fourth quarter and fiscal year 2024 which ended April 26, 2024. NetApp executive management will host a conference call at 2:30 p.m. Pacific Time to...

at 16:05
Longboard Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today provided a corporate update and reported first quarter 2024 financial results. "I am...

at 16:05
4M Therapeutics Inc., an early-stage biotechnology company developing treatments for neuropsychiatric and neurodegenerative conditions, today announced the formation of its Clinical Advisory Board comprised of five physician scientists and leaders in...

at 16:05
Arrowhead Pharmaceuticals, Inc. today announced a $50 million milestone payment was received from Royalty Pharma plc . This milestone was triggered after the completion of enrollment of the Phase 3 OCEAN(a) - Outcomes Trial of olpasiran, being...



News published on and distributed by: